Literature DB >> 11698819

Hearing improvement after middle fossa resection of vestibular schwannoma.

K R Stidham1, J B Roberson.   

Abstract

OBJECTIVE: The preoperative, intraoperative, and postoperative variables of patients experiencing hearing improvement after middle fossa resection of vestibular schwannomas were evaluated as potential prognostic indicators. STUDY
DESIGN: Retrospective case review with new objective postoperative data collected on patients with documented hearing improvement.
SETTING: California Ear Institute at Stanford and Stanford University Hospital, a tertiary referral center. PATIENTS: The patient group consisted of 30 consecutive patients undergoing middle fossa approach to vestibular schwannoma between October 24, 1994, and November 11, 1998. INTERVENTION: Hearing preservation surgery via the middle cranial fossa approach was performed on all patients. MAIN OUTCOME MEASURES: Pure-tone averages (PTAs) and speech discrimination scores (SDS) were used to document hearing preoperatively and postoperatively. Preoperative electrophysiologic studies of auditory brainstem response, electronystagmography, electrical neuronography, transient evoked otoacoustic emissions, and distortion product otoacoustic emissions were evaluated. Intraoperative continuous nerve action potential and auditory brainstem response tracings were reviewed. Postoperative auditory brainstem response and transient evoked otoacoustic emissions were obtained when possible on patients whose hearing improved. Statistical analysis was completed using Student's t test and chi-square test.
RESULTS: Seventeen (57%) of 30 patients with tumors ranging from 2 to 31 mm maintained hearing postoperatively. Among patients with hearing preservation, 7 (41% or 23% of the overall group) exhibited hearing improvement (PTA 2 improved by > or =5 dB and/or SDS improved by > or =12%). Three of these 7 patients moved from nonfunctional (AAOHNS class C/D) to functional (AAOHNS class A/B) categories. All patients who enjoyed postoperative hearing improvement had preoperative absence or abnormality of ABRs. No patient with normal preoperative ABR experienced hearing improvement. Hearing improvement patients also had lower preoperative caloric function on electronystagmography compared with the entire group (p < 0.02) and were more likely to have superior vestibular nerve tumors. No differences were noted for electrical neurography and otoacoustic emissions.
CONCLUSIONS: Middle fossa resection of vestibular schwannoma offers patients the possibility of hearing improvement after treatment. The chance of hearing improvement is significantly higher than with other forms of treatment such as radiation therapy or translabyrinthine surgery. Although preoperative ABR abnormality may be an indicator of poor prognosis for hearing preservation, those patients who enjoy hearing improvement come from the group of patients with abnormal preoperative ABRs. Other factors identified as associated with hearing improvement include poor SDS with more normal PTA 2, and significantly decreased electronystagmographic caloric function (as an indicator of superior vestibular nerve tumors). Hearing improvement to the functional range after surgical resection is possible in some patients previously thought to be poor candidates for hearing preservation attempts. Hearing improvement may continue for many months after surgery.

Entities:  

Mesh:

Year:  2001        PMID: 11698819     DOI: 10.1097/00129492-200111000-00035

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  7 in total

1.  Outcome on hearing and facial nerve function in microsurgical treatment of small vestibular schwannoma via the middle cranial fossa approach.

Authors:  Christian Ginzkey; Matthias Scheich; Wilma Harnisch; Verena Bonn; Desiree Ehrmann-Müller; Wafaa Shehata-Dieler; Robert Mlynski; Rudolf Hagen
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-22       Impact factor: 2.503

2.  Clinical features of vestibular schwannomas in patients who experience hearing improvement after surgery.

Authors:  Michihiro Kohno; Shigeo Sora; Hiroaki Sato; Masanobu Shinogami; Hidehiko Yoneyama
Journal:  Neurosurg Rev       Date:  2014-12-21       Impact factor: 3.042

Review 3.  Hearing improvement after vestibular schwannoma surgery in the era of the hearing preservation rule - case report and literature review.

Authors:  Zdenek Fik; Jan Lazak; Silvie Hruba; Zdenek Cada; Eduard Zverrna; Jan Betka
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-12-09       Impact factor: 1.648

4.  Hearing improvement after tumor removal in a vestibular schwannoma patient with severe hearing loss.

Authors:  Y Inoue; K Ogawa; J Kanzaki
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-08       Impact factor: 2.503

Review 5.  Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.

Authors:  Scott R Plotkin; Chris Halpin; Jaishri O Blakeley; William H Slattery; D Bradley Welling; Susan M Chang; Jay S Loeffler; Gordon J Harris; A Gregory Sorensen; Michael J McKenna; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

6.  Hearing improvement after resection of a large jugular foramen schwannoma: case report.

Authors:  Gregory P Lekovic; L Fernando Gonzalez; Peter Weisskopf; Kris A Smith
Journal:  Skull Base       Date:  2008-05

7.  Audiovestibular Function Deficits in Vestibular Schwannoma.

Authors:  Constantin von Kirschbaum; Robert Gürkov
Journal:  Biomed Res Int       Date:  2016-09-22       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.